Aster DM Healthcare Ltd

  • BSE Code : 540975
  • NSE Symbol : ASTERDM
  • ISIN : INE914M01019
  • Industry :HEALTHCARE

up-arrow 620.15 -11.90(-1.88%)

Open Price ()

634.40

Prev. Close ()

632.05

Volume (No’s)

1,287,883

Market Cap ()

32,131.28

Low Price ()

613.85

High Price ()

634.40

 

Board Meetings

Start Date End Date Purpose
25-Jul-2025 30-Jul-2025 Aster DM Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2025 inter alia to consider and approve Intimation of Board Meeting to consider the unaudited financial results for the quarter ended June 30 2025 as per annexure attached (As per BSE Announcement Dated on 30/07/2025)
14-May-2025 20-May-2025 Aster DM Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 inter alia to consider and approve The meeting of the Board of Directors of the Company is scheduled on 20/05/2025 inter alia to 1. consider and approve the audited financial results (both standalone and consolidated) for the quarter and year ended March 31 2025 2. recommend final dividend if any for the financial year 2024-25. Outcome of Board Meeting (As Per BSE Announcement Dated on: 20/05/2025)
27-Jan-2025 31-Jan-2025 Aster DM Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI Listing Regulations we hereby inform you that a meeting of the Board of Directors of Aster DM Healthcare Limited (Company) is scheduled to be held on Friday January 31 2025 inter alia to: 1. Consider and approve the unaudited financial results (both standalone and consolidated) of the Company for the quarter ended December 31 2024 2. Consider declaration of interim dividend for the financial year 2024-25. We request you to kindly take the above information on record. Outcome of Board Meeting - Financial Results, Interim Dividend Results - Financial Results for the Quarter ended December 31, 2024 Board approves Interim Dividend (As per BSE Announcement Dated on 31/01/2025)
26-Nov-2024 29-Nov-2024 Aster DM Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/11/2024 inter alia to consider and approve 1. To evaluate and approve the proposal for issuance of equity shares by way of preferential allotment of up to 5% paid-up capital of the Company (on post issue basis) in accordance with the applicable laws subject to such regulatory/statutory approvals as may be required and the approval of shareholders of the Company. 2.To consider conducting the postal ballot to seek the approval of shareholders inter alia in respect of aforesaid proposal if the same is approved by the Board. 3.ln compliance with SEBI (PIT) Regulations 2015 the Trading Window for dealing in securities of the Company shall be closed for all Designated Persons from the intimation of this notice up to 48 hours from the time of disclosure of outcome of the above meeting to the Stock Exchanges. 4.Regulation 30 of Securities and Exchange Board of India (LODR) Regulation 2015 we wish to inform you that an investors conference call is scheduled on Nov 29 2024. The Board of Directors at their meeting held on 29th November 2024 have, inter alia, approved a preferential allotment for consideration other than cash, shifting of registered office, amalgamation, postal ballot notice and entered into a merger framework agreement ('MFA'), Shareholders' Agreement (SHA) and certain other agreements in relation to foregoing matters. Kindly take the above said information on record. The Board of Directors at their meeting held on 29.11.2024, approved the shifting of registered office of the Company from the state of Karnataka to the state of Telangana subject to approval of the shareholders of the Company and approval of Regional Director. Kindly take the above said information on record. (As Per BSE Announcement Dated on 29.11.2024)
17-Oct-2024 23-Oct-2024 Aster DM Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve the Unaudited Financial Results (both standalone and consolidated) of the Company for the quarter and half year ended September 30 2024. Please find the unaudited financial results (Standalone and consolidated) for the quarter and half year ended September 30, 2024 along with the Limited review report. Please find the financial results for quarter and half year ended September 30,2024 along with limited review report Please find enclosed the unaudited financial results for the quarter and half year ended September 30,2024 (As per BSE Announcement Dated on 23/10/2024)

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew